Recommendations for the pharmacological management of neuropathic pain: An overview and literature update

Robert H. Dworkin, Alec B. O'Connor, Joseph Audette, Ralf Baron, Geoffrey K. Gourlay, Maija L. Haanpää, Joel L. Kent, Elliot J. Krane, Alyssa A. LeBel, Robert M. Levy, Sean C. Mackey, John Mayer, Christine Miaskowski, Srinivasa N. Raja, Andrew S.C. Rice, Kenneth E. Schmader, Brett Stacey, Steven Stanos, Rolf Detlef Treede, Dennis C. TurkGary A. Walco, Christopher D. Wells

Research output: Contribution to journalReview article

871 Scopus citations

Abstract

The Neuropathic Pain Special Interest Group of the International Association for the Study of Pain recently sponsored the development of evidence-based guidelines for the pharmacological treatment of neuropathic pain. Tricyclic antidepressants, dual reuptake inhibitors of serotonin and norepinephrine, calcium channel α2-δ ligands (ie, gabapentin and pregabalin), and topical lidocaine were recommended as first-line treatment options on the basis of the results of randomized clinical trials. Opioid analgesics and tramadol were recommended as second-line treatments that can be considered for first-line use in certain clinical circumstances. Results of several recent clinical trials have become available since the development of these guidelines. These studies have examined botulinum toxin, high-concentration capsaicin patch, lacosamide, selective serotonin reuptake inhibitors, and combination therapies in various neuropathic pain conditions. The increasing number of negative clinical trials of pharmacological treatments for neuropathic pain and ambiguities in the interpretation of these negative trials must also be considered in developing treatment guidelines. The objectives of the current article are to review the Neuropathic Pain Special Interest Group guidelines for the pharmacological management of neuropathic pain and to provide a brief overview of these recent studies.

Original languageEnglish (US)
Pages (from-to)S3-S14
JournalMayo Clinic Proceedings
Volume85
Issue number3 SUPPL.
DOIs
StatePublished - Mar 2010

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dworkin, R. H., O'Connor, A. B., Audette, J., Baron, R., Gourlay, G. K., Haanpää, M. L., Kent, J. L., Krane, E. J., LeBel, A. A., Levy, R. M., Mackey, S. C., Mayer, J., Miaskowski, C., Raja, S. N., Rice, A. S. C., Schmader, K. E., Stacey, B., Stanos, S., Treede, R. D., ... Wells, C. D. (2010). Recommendations for the pharmacological management of neuropathic pain: An overview and literature update. Mayo Clinic Proceedings, 85(3 SUPPL.), S3-S14. https://doi.org/10.4065/mcp.2009.0649